Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma

Minghong Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dexian Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College)
BMC Cancer
February 3, 2011
10.1186/1471-2407-11-54
Cited by 34

Related Papers

TRAIL receptor mediates inflammatory cytokine release in an NF-κB-dependent manner
|Cell Research|2009|55
HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species
|PLoS ONE|2011|50
Death receptor 6 (DR6) is required for mouse B16 tumor angiogenesis via the NF-κB, P38 MAPK and STAT3 pathways
|Oncogenesis|2016|24
An agonistic monoclonal antibody against DR5 induces ROS production, sustained JNK activation and Endo G release in Jurkat leukemia cells
|Cell Research|2009|15